Evidence map›Paper›PMID 35079976›Full record

ArticleJournal of endocrinological investigation2022

A decrease in serum 1,25(OH)

J Vaculik, L Wenchich, M Bobelyak, K Pavelka, J J Stepan

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of endocrinological investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

J VaculikOrthopedic Department, Bulovka Hospital, Prague, Czech Republic.
L WenchichInstitute of Rheumatology, Prague, Czech Republic.
M BobelyakOrthopedic Department, Bulovka Hospital, Prague, Czech Republic.
K PavelkaInstitute of Rheumatology, Prague, Czech Republic.
J J StepanInstitute of Rheumatology, Prague, Czech Republic. stepan@revma.cz.ORCID http://orcid.org/0000-0003-1541-8306
Charles University · CZInstitute of Rheumatology · CZ

Funding

Office of Research and Development 00023728
6 · The paper itself

Abstract

objectiveAlthough calcitriol is essential for bone healing, its serum concentrations are low after hip surgery, and they continue to decline during bone healing. This study aimed to test the hypothesis of an association of changes in calcitriol production with the status of fibroblast growth factor 23 (FGF23) and iron deficiency after elective hip replacement for coxarthrosis.

methodsIn this prospective study, we measured the biomarkers of 17 patients undergoing elective hip replacement on admission, on the first day after surgery, and at the regular check-up after 48 ± 8 days. The serum concentrations of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, transferrin, ferritin, parathyroid hormone, intact plasma FGF23 (iFGF23) and C-terminal FGF23 (cFGF23) were determined.

resultsIn our patients who underwent elective hip replacement, significant correlations existed between the percent change in the conversion rate of 25(OH)D to 1,25(OH)

conclusionsThe production of calcitriol is compromised after elective hip replacement surgery, leading to reduced levels of active vitamin D in the serum. Significant correlations between the percent change in the conversion rate of 25(OH)D to 1,25(OH)

Indexed as

CalcitriolFibroblast Growth FactorsHumansIronParathyroid HormoneProspective StudiesVitamin DCalcitriolFibroblast Growth FactorsIronParathyroid HormoneVitamin DCalcitriolElective hip replacementFibroblast growth factor 23IronTotal 25 hydroxyvitamin D

Identifiers

PMID35079976
OpenAlexW4210692185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.